AUD 0.09
(6.9%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 12.26 Million AUD | 46.52% |
2023 | 8.37 Million AUD | -20.95% |
2022 | 10.59 Million AUD | 156.27% |
2021 | 4.13 Million AUD | 404.23% |
2020 | 819.55 Thousand AUD | 51.67% |
2019 | 540.33 Thousand AUD | -3.51% |
2018 | 560.01 Thousand AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 12.26 Million AUD | 46.52% |
2024 Q1 | 8.42 Million AUD | 0.61% |
2024 Q3 | 12.26 Million AUD | 45.63% |
2024 Q4 | 12.26 Million AUD | 0.0% |
2024 Q2 | 8.42 Million AUD | 0.0% |
2023 Q3 | 8.37 Million AUD | 5.49% |
2023 FY | 8.37 Million AUD | -20.95% |
2023 Q4 | 8.37 Million AUD | 0.0% |
2023 Q1 | 7.93 Million AUD | -25.07% |
2023 Q2 | 7.93 Million AUD | 0.0% |
2022 Q1 | 12 Million AUD | 190.44% |
2022 FY | 10.59 Million AUD | 156.27% |
2022 Q4 | 10.59 Million AUD | 0.0% |
2022 Q3 | 10.59 Million AUD | -11.76% |
2022 Q2 | 12 Million AUD | 0.0% |
2021 Q3 | 4.13 Million AUD | 371.35% |
2021 Q2 | 876.73 Thousand AUD | 0.0% |
2021 Q1 | 876.73 Thousand AUD | 6.98% |
2021 FY | 4.13 Million AUD | 404.23% |
2021 Q4 | 4.13 Million AUD | 0.0% |
2020 FY | 819.55 Thousand AUD | 51.67% |
2020 Q4 | 819.55 Thousand AUD | 0.0% |
2020 Q3 | 819.55 Thousand AUD | 0.0% |
2020 Q1 | - AUD | 0.0% |
2019 FY | 540.33 Thousand AUD | -3.51% |
2018 FY | 560.01 Thousand AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Australian Clinical Labs Limited | 593.06 Million AUD | 97.932% |
Genetic Signatures Limited | 67.28 Million AUD | 81.771% |
Genetic Technologies Limited | 6.18 Million AUD | -98.263% |
Healius Limited | 2.98 Billion AUD | 99.589% |
Imagion Biosystems Limited | 4.58 Million AUD | -167.442% |
Integral Diagnostics Limited | 744.27 Million AUD | 98.352% |
INOVIQ Ltd | 21.7 Million AUD | 43.491% |
Microba Life Sciences Limited | 58.04 Million AUD | 78.867% |
Monash IVF Group Limited | 508.47 Million AUD | 97.588% |
Rhythm Biosciences Limited | 1.51 Million AUD | -707.634% |
Sonic Healthcare Limited | 14.82 Billion AUD | 99.917% |